It could treat DNA sequencing like genetic tests and require separate approvals for each use.
It slowly dawned on Rothberg that a sensor like that could be used for DNA sequencing.
The DNA sequencing and the data analysis will be compliant with regulations for lab diagnostics.
Each sample is catalogued and photographed before extracts are run through a DNA sequencing process.
To do so, it uses the DNA sequencing machines made by Illumina and other companies.
In the next generation of DNA sequencing, routine DNA analysis in the clinical setting is not far off.
As a result of all of this competition and new technologies, DNA sequencing has gotten cheaper with incredible speed.
FORBES: What Does This $14 Billion Deal Mean For The Future Of DNA Sequencing?
Even with such an approval, there are pretty big regulatory and reimbursement hurdles for getting DNA sequencing into hospitals.
He hopes that new high-speed DNA sequencing machines will help fix that issue.
FORBES: Gleevec Inventor: Why Aren't There More Cancer Cures?
This is partly because the cost of DNA sequencing is being consumerized by both instrument innovations and the cloud.
Cancer patients may be among the first to benefit from DNA sequencing technology.
Matthew Herper has a spectacular story out this week on DNA sequencing.
The results of large-scale DNA sequencing studies of cancer genomes are very clear.
Last year we used DNA sequencing to help bring an outbreak of MRSA at Addenbrooke's hospital in Cambridge to a halt.
In the latest work, the team, from London and the University of Oxford, used DNA sequencing methods to study XMRV.
The deal would come as the cost is declining and the scientific potential is rising for DNA sequencing, experts say.
The ability to do this is remarkably enhanced when we include patient data generated with new with tools like DNA sequencing.
FORBES: Moving Healthcare from the 'Mad Men' Era into the Big Data Age
In the same breath, the article mentions DNA sequencing company Pacific Biosciences, as well as Glaukos and NeuroPace which sell medical devices.
FORBES: Why The Numbers On Health IT Venture Funding Are Confusing
But as the cost of DNA sequencing dropped, Knome found its business focused more on researchers who wanted help analyzing DNA samples.
In an August Forbes blog post, science writer Matthew Herper reminds us that Illumina is still the dominant force in DNA sequencing.
The chief executive of a major maker of DNA sequencing technology is talking about getting regulatory clearance to use his technology for medical purposes.
Investors are betting that, given the headway being made in DNA sequencing, it is undervalued compared to larger rivals like Illumina and Life Technologies.
The report comes amid surging interest at major cancer centers in analyzing tumor tissue with DNA sequencing and other technologies to determine customized treatments.
But competition is already hotter than many people probably expected, with other new outfits bringing forth other technologies that could make DNA sequencing even cheaper.
Another has perfectly arrayed pores 3 nanometers across, a mesh so fine it is used to filter individual amino acids in the DNA sequencing process.
There are some accounts that this is starting to happen, but Memford says she still does all her DNA sequencing using research, not insurance, funding.
FORBES: DNA Sequencing: Is Science Fiction Becoming Medical Fact?
Although genomics stocks are crashing, I think we picked the right character in Rothberg, who has been part of the DNA sequencing race from the beginning.
In a series of videos on the Web site of Cold Spring Harbor Laboratory, he discussed his role in the early days of DNA sequencing.
FORBES: David Cox, Genomics Pioneer Emblematic Of Pfizer's New Era, Dies Unexpectedly
The first case of a diagnosis by DNA sequencing was published in 2009, when Yale researchers figured out why a Turkish infant was suddenly losing weight.
FORBES: Sequencing A Child's DNA -- And Convincing An Insurance Company To Pay
The winner, hands down, is Illumina, the leading maker of DNA sequencing equipment, which has delivered a total return to investors of nearly 800% since late 2005.
应用推荐